Literature DB >> 22231930

Multimodality imaging for assessment of myocardial viability: nuclear, echocardiography, MR, and CT.

James A Arrighi1, Vasken Dilsizian.   

Abstract

The assessment of myocardial viability may be an important component of the evaluation of patients with coronary artery disease and left ventricular dysfunction. The primary goal of viability assessment in such patients is to guide therapeutic decisions by determining which patients would most likely benefit from revascularization. In patients with chronic coronary artery disease, left ventricular dysfunction may be a consequence of prior myocardium infarction, which is an irreversible condition, or reversible ischemic states such as stunning and hibernation. Imaging techniques utilize several methods to assess myocardial viability: left ventricular function, morphology, perfusion, and metabolism. Each technique (echocardiography, nuclear imaging, magnetic resonance imaging, and x-ray computed tomography) has the ability to assess one or more of these parameters. This article describes how each of these imaging modalities can be used to assess myocardial viability, and reviews the relative strengths and limitations of each technique.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231930     DOI: 10.1007/s11886-011-0242-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  58 in total

Review 1.  Assessment of myocardial viability by radionuclide and echocardiographic techniques: is it simply a sensitivity and specificity issue?

Authors:  James A Arrighi; Vasken Dilsizian
Journal:  Curr Opin Cardiol       Date:  2006-09       Impact factor: 2.161

2.  Myocardial positive pre-ejection velocity accurately detects presence of viable myocardium, predicts recovery of left ventricular function and bears a prognostic value after surgical revascularization.

Authors:  Martin Penicka; Petr Tousek; Bernard De Bruyne; William Wijns; Otto Lang; Juraj Madaric; Marc Vanderheyden; Jaroslav Tintera; Marek Malý; Petr Widimsky; Jozef Bartunek
Journal:  Eur Heart J       Date:  2007-01-05       Impact factor: 29.983

3.  18F-FDG uptake as a surrogate marker for antecedent ischemia.

Authors:  Vasken Dilsizian
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

4.  Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts.

Authors:  H Baumgartner; G Porenta; Y K Lau; M Wutte; U Klaar; M Mehrabi; R J Siegel; J Czernin; G Laufer; H Sochor; H Schelbert; M C Fishbein; G Maurer
Journal:  J Am Coll Cardiol       Date:  1998-11-15       Impact factor: 24.094

5.  13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization.

Authors:  A N Kitsiou; S L Bacharach; M L Bartlett; G Srinivasan; R M Summers; A A Quyyumi; V Dilsizian
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

6.  Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.

Authors:  F Haas; C J Haehnel; W Picker; S Nekolla; S Martinoff; H Meisner; M Schwaiger
Journal:  J Am Coll Cardiol       Date:  1997-12       Impact factor: 24.094

7.  Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography.

Authors:  P Perrone-Filardi; L Pace; M Prastaro; F Squame; S Betocchi; A Soricelli; F Piscione; C Indolfi; T Crisci; M Salvatore; M Chiariello
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

8.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

Review 9.  Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.

Authors:  Raymond Y Kwong; Hema Korlakunta
Journal:  Top Magn Reson Imaging       Date:  2008-02

10.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

View more
  4 in total

Review 1.  The Role of Cardiac Computed Tomography in Heart Failure.

Authors:  Spencer S Kitchin; Venkat Sanjay Manubolu; Sion K Roy; Matthew J Budoff
Journal:  Curr Heart Fail Rep       Date:  2022-05-19

2.  Coronary artery angiography and myocardial viability imaging: a 3.0-T contrast-enhanced magnetic resonance coronary artery angiography with Gd-BOPTA.

Authors:  Hong Yun; Hang Jin; Shan Yang; Dong Huang; Zhang-wei Chen; Meng-su Zeng
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-26       Impact factor: 2.357

3.  Cardiac Magnetic Resonance Imaging used for Evaluation of Adipose-Derived Stromal Cell Therapy in Patients with Chronic Ischemic Heart Disease.

Authors:  Abbas Ali Qayyum; Anders Bruun Mathiasen; Naja Dam Mygind; Niels Groove Vejlstrup; Jens Kastrup
Journal:  Cell Transplant       Date:  2019-11-08       Impact factor: 4.064

4.  Twenty four hour imaging delay improves viability detection by Tl-201 myocardial perfusion scintigraphy.

Authors:  Zehra Pınar Koç; Tansel Ansal Balcı; Necati Dağlı
Journal:  Rev Bras Cir Cardiovasc       Date:  2013 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.